Objectives: The bacterial pathogen Neisseria meningitidis is able to escape the currently available capsule-based vaccines by undergoing capsule switching. In this study, we investigated whether capsule switching has occurred in a recently emerged sequence type (ST) 7 serogroup X isolate in China, for which currently no vaccine is available.
Methods: To identify capsule switching breakpoints, the capsule locus and flanking regions of the ST-7 serogroup X isolate and three endemic ST-7 serogroup A isolates were sequenced and compared. To obtain further insight into capsule switching frequency and length of DNA fragments involved, capsule switching assays were performed using genomic DNA containing combinations of antibiotic selection markers at various locations in the capsule locus and flanking regions.
Results: Sequence analyses showed that capsule switching has occurred and involved a 8450 bp serogroup X DNA fragment spanning the region from galE to ctrC. Capsule switching assays indicate that capsule switching occurs at a frequency of 6.3 × 10 per bacterium per μg of DNA and predominantly involved DNA fragments of about 8.1-9.6 kb in length.
Conclusions: Our results show that capsule switching in N. meningitidis occurs at high frequency and involves recombination in the flanking regions of the capsule biosynthesis genes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jinf.2017.09.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Idiopathic encapsulating peritoneal sclerosis: A case report.
Int J Surg Case Rep
November 2024
B Surgery Department, Charles Nicolle Hospital, Tunis, Tunisia.
Article Synopsis
- Encapsulating peritoneal sclerosis (EPS) is a rare condition that can present symptoms similar to other diseases, often leading to misdiagnosis; in this case, it was confused with an internal hernia.
- A 52-year-old male experienced abdominal pain and bloating for six months, and imaging suggested an internal hernia, but surgery revealed EPS with fibrous tissue encasing the bowel.
- EPS symptoms are caused by a thick capsule around the intestines, typically linked to peritoneal dialysis or inflammatory disorders, and treatment varies from managing underlying causes to surgical interventions, which carry risks of recurrence and high mortality.
Clinical management of hypophosphatemic osteomalacia induced by adefovir and tenofovir: Insights from a case report.
Medicine (Baltimore)
November 2024
Department of Endocrinology, Lishui Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang Province, China.
Article Synopsis
- Hypophosphatemic osteomalacia is a rare condition marked by low phosphate levels, which can occur due to genetic or acquired factors, and a case study discusses its management and prognosis when caused by specific antiviral drugs.
- A 55-year-old man with chronic hepatitis B experienced symptoms like chest pain and fatigue after switching from adefovir to tenofovir, leading to the diagnosis of drug-induced hypophosphatemic osteomalacia.
- Treatment included stopping the problematic drugs, switching to entecavir, and recommending dietary changes and supplements, which resulted in improved phosphate levels and resolution of symptoms.
Temperature-responsive gating chitosan-based microcapsules for controlled release of urea fertilizers.
Carbohydr Polym
January 2025
School of Chemistry and Chemical Engineering, Guangxi Key Laboratory of Petrochemical Resource Processing and Process Intensification Technology, Guangxi University, Nanning 530004, China; State Key Laboratory Breeding Base of Green-Chemical Synthesis Technology, Institute of Green Petroleum Processing and Light Hydrocarbon Conversion, College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, China.
Polysaccharides-based smart fertilizers are essential for promoting plant growth, yet significant challenges exist in achieving stable structures and synchronizing nutrient release and plant growth. This study developed a temperature-responsive gating chitosan-based microcapsule (CTSMC-g-PNIPAM) by grafting N-isopropyl acrylamide (NIPAM) onto chitosan microcapsules (CTSMC) via atom transfer radical polymerization (ATRP). The interfacial crosslinking of chitosan (CTS) and terephthalendehyde (TPA) formed the CTSMC matrix with a hollow chamber structure and ensured stability.
View Article and Find Full Text PDFPhase I Clinical Study of a Multi-Kinase Inhibitor TG02 Capsule for the Treatment of Recurrent High-Grade Gliomas with Failed Temozolomide Treatment in Chinese Patients.
Chemotherapy
November 2024
Department of Neurosurgery/Neuro-Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Introduction: We report the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of a multi-kinase inhibitor (TG02 capsule) as a new therapy for patients with recurrent high-grade gliomas in China.
Methods: This is a single-center, dose-escalation, open-label phase I study, which enrolled patients with recurrent high-grade gliomas who failed to temozolomide. Patients were assigned sequentially into different dose groups and received TG02 every 4 weeks.
Stereodivergent Macrocyclization in Dynamic Chiral Confinement.
Chemistry
November 2024
Department of Chemistry, State Key Lab of Molecular Engineering of Polymers, Shanghai Key Lab of Molecular Catalysis and Innovative Materials, Fudan University, Shanghai, China.
The absolute and relative configurations of a macrocyclic natural product bearing multiple chirality have a crucial influence on its physical and biological properties. Nevertheless, their preparation with full stereocontrol remains largely unexplored in synthetic community. Here, we show a stereodivergent macrocyclization under dynamic chiral confinement in which the stepwise chirality switching of a chiral space directs complete stereocontrol.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!